Why the study?
Does Shenxian-shengmai (SXSM) oral liquid improve cardiac function and reduce oxidative stress in a rat model of myocardial ischemia-reperfusion injury?
Does Shenxian-shengmai (SXSM) oral liquid improve cardiac function and reduce oxidative stress in a rat model of myocardial ischemia-reperfusion injury?
Shenxian-shengmai oral liquid protects against myocardial ischemia-reperfusion injury and improves cardiac function in rats by reducing oxidative stress via SOD1 and GCLC pathways.
No takes yet. Share an insight, caveat, or question.
SXSM may attenuate myocardial I/R injury in animals; leaves open any clinical role in human bradyarrhythmias or reperfusion.
Zhao et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: